12.01
12.01 (0.60%)
As of Nov 27, 2023
Aeglea Biotherapeutics, Inc. [AGLE]
Source:
Company Overview
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company utilizing potential best-in-class antibody engineering, dose optimization, and rational therapeutic combinations to target improved efficacy and convenience in the treatment of IBD and other immune-mediated diseases.
| Country | United States |
| Headquarters | austin, texas |
| Phone Number | (512) 942-2935 |
| Industry | manufacturing |
| CEO | Cameron Turtle, D.Phil |
| Website | aeglea.com |